FileMaker Pro 11 and FileMaker Pro Advanced 11 (PC World)
A year after the release of the FileMaker 10 database program, version 11 has arrived, with new tools and great new features that make it even easier to use...
FileMaker Pro 11 and FileMaker Pro Advanced 11 (Network World)
A year after the release of the FileMaker 10 database program, version 11 has arrived, with new tools and great new features that make it even easier to use. FileMaker 11 also puts many cool database tricks within the reach of ordinary users. FileMaker 11 may be the best FileMaker ever.
CA Receives Top 'Product of the Year' and 'Partner of the Year' Honors from Programmer's Paradise (PR Newswire via Yahoo! Finance)
CA, Inc. today announced it was named Partner of the Year for the second straight year by leading IT reseller Programmer's Paradise.  Also for the second straight year, CA ERwin® Modeling Suite earned the vendor's highest Riding the Crest® award for best-selling Product of the Year, while CA ARCserve® Backup, CA Threat Manager, and CA eHealth® Performance Manager won in seven other product ...
NOVACES Selected for $1.3B Human Resources Services ID/IQ (PRWeb via Yahoo! News)
NOVACES to Provide Continuous Process Improvement, Project and Program Management, and Studies and Analysis Support to Defense Department Under Multiple Award Contract
HealthCentral Names Sastry Nanduri Chief Technology Officer (PR Newswire via Yahoo! Finance)
HealthCentral , the leading collection of online condition-specific consumer health and wellness experiences, announced today that Sastry Nanduri will become Chief Technology Officer, driving the company's global engineering efforts.
Press Release (PharmiWeb)
Pfizer Inc. Posted on:05 Mar 10 Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc. (NYSE: PFE), was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet ...
ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior To Enoxaparin In ... (Finanzen.net)
Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company (NYSE: ...
ADVANCE-2 Study Results Demonstrate Investigational Anticoagulant Apixaban Was Statistically Superior To Enoxaparin In ... (Business Wire via Yahoo! Finance)
PRINCETON, N.J. & NEW YORK----Apixaban, an oral anticoagulant being developed by Bristol-Myers Squibb Company and Pfizer Inc. , was statistically superior to 40 mg once daily enoxaparin in reducing the incidence of venous thromboembolism in patients undergoing elective total knee replacement surgery, according to the ADVANCE-2 study results published today in The Lancet.
Cubic to Provide Training and Education Support On Team Assisting U.S. Army Human Resources Programs (Defence Professionals)
LEAVENWORTH, Kansas | Cubic Applications, Inc., a mission support services subsidiary of Cubic Corporation (NYSE: CUB), will provide military training and education support to U.S. Army’s human...
Masters programme in Geoinformatics in Kashmir Univ (New Kerala)
Srinagar, Mar 3 : The Kashmir University (KU) has decided to start Master's programme in Geoinformatics, a frontier field of Science, at the Department of Geology and Geophysics from the academic session 2010-11.